SIMULTANEOUS MEASUREMENT OF PELVIC FLOOR ACTIVITY, VAGINAL PLETHYSMOGRAPHY AND VAGINAL INNERVATION IN WOMEN WITH AND WITHOUT HYPERACTIVE PELVIC FLOOR SYNDROME.

SIMULTANEOUS MEASUREMENT OF PELVIC FLOOR ACTIVITY, VAGINAL PLETHYSMOGRAPHY AND VAGINAL INNERVATION IN WOMEN WITH AND WITHOUT HYPERACTIVE PELVIC FLOOR SYNDROME. - HyPelM-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30865

Enrollment

Registered

2007-07-18

Start date

2007-04-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperactive Plevic Floor Syndrome

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria both groups: 1. No sexual compaints for at least one year and sexually active. 2. Heterosexual orientation. 3. Willing to provide informed consent. 4. Control group: Subjects are medically healthy and have no complaints that point to problems with the pelvic floor. 5. Pelvic floor hypertonia group: Dyspareunia and co-morbidity of three or more symptoms that corrrelate with pelvic floor dysfunctions such as chronic abdominal pain, irritable bowel syndrome, constipation, diarrhea, urethra syndrome, overactive bladder, intercistal cystitis, vulvodynia, sexual arousal disorder, peri-anal pain, haemorrhoids, perineal pain, coccydynia, orgasm pain, lower back pain, muscle ache in other body parts such as neck or shoulders, headache, teeth gnashing, hyperventilation.

Exclusion criteria

Exclusion criteria: Exclusion criteria both groups: 1. Sexual complaints of shorter duration than one year. 2. Pregnancy and lactation. 3. Menstruation during measurement days. 4. Use of medication negatively influencing sexual function or vaginal vasocongestion. 5. Use of drugs 24 hours prior to testing. 6. Affective, psychotic, or substance-abuse disorders. 7. Pelvic floor hypertonia group: chronic pelvic floor hypertonia with generalized secundary vaginismus.

Design outcomes

Primary

Measure	Time frame
It is expected that - the control group will show a larger EMG increase during the voluntary control excercises than the experimental group; - the control group will exhibit lower tonus- and higher controlscores in the pelvic floor exam than the experimental group; - both groups of women will show hightened EMG activity during the threatening and sexually threatening film clips; - both groups of women will demonstrate hightened VPA amplitude during the erotic flm clip compared to baseline, but the experimental groups VPA will be lower than the control groups VPA; - women with an increased tonus of the pelvic floor will have a lower threshold for perceiving stimuli (they will exhibit increased vaginal innervation)	—

Measure

Time frame

It is expected that - the control group will show a larger EMG increase during the voluntary control excercises than the experimental group; - the control group will exhibit lower tonus- and higher controlscores in the pelvic floor exam than the experimental group; - both groups of women will show hightened EMG activity during the threatening and sexually threatening film clips; - both groups of women will demonstrate hightened VPA amplitude during the erotic flm clip compared to baseline, but the experimental group*s VPA will be lower than the control group*s VPA; - women with an increased tonus of the pelvic floor will have a lower threshold for perceiving stimuli (they will exhibit increased vaginal innervation)

—

Secondary

Measure	Time frame
It is expected that little control over the pelvic floormuscles as measured in the pelvic floor exam will be related to a reduced EMG variability during the flick excercises.	—

Countries

Netherlands

Outcome results